- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| Fr | Context Therapeutics - CTIM-76 selected as clinical CLDN6 candidate | 229 | In an encouraging pipeline development, Context Therapeutics has announced the selection of a final clinical candidate for its second R&D program, a CLDN6xCD3 bispecific antibody. The nominated candidate... ► Artikel lesen | ||
| Fr | paragon - Agreement to sell paragon semvox | 271 | paragon has announced that it is to sell its digital assistance business unit, paragon semvox, to CARIAD, the wholly owned software subsidiary of Volkswagen. The anticipated price is c €40m, which equates... ► Artikel lesen | ||
| Do | Henderson International Income Trust - Beating inflation with covered dividend | 200 | Henderson International Income Trust (HINT) has succeeded in achieving its dual objectives of capital gains and a high and growing dividend. Annualised NAV total return (TR) of 9.4% over the 10 years... ► Artikel lesen | ||
| Do | Treatt - Rebuilding confidence | 197 | Treatt's FY22 results were in line with the revised guidance issued in August. Management once again explained the steps that have been taken to improve processes around sales pricing and cost recovery... ► Artikel lesen | ||
| Do | Baillie Gifford China Growth Trust - Finding big trendsetters amid 'little giants' | 140 | Baillie Gifford China Growth Trust (BGCG) invests in China, aiming to capture current trendsetters and spot future potential market leaders, for a long-term time horizon (typically over five years).... ► Artikel lesen | ||
| Do | Scandion Oncology - Francois Martelet appointed as CEO | 172 | Scandion Oncology has announced the appointment of Francois Martelet, MD, as CEO, effective from 2 January 2023, when he will take over from acting CEO and CFO Johnny Stilou. Francois brings more than... ► Artikel lesen | ||
| Do | discoverIE Group - Focused on sustainable growth | 141 | discoverIE reported another strong set of results for H123 despite ongoing supply chain challenges, with 14% y-o-y organic revenue growth, 37% EPS growth and a record end-H1 order book. As the company... ► Artikel lesen | ||
| Do | GB Group - H123 performance masks strategic progress | 175 | GB Group (GBG) reported a mixed performance in H123: strong growth in its Fraud and Location businesses was offset by weaker performance in the Identity business resulting in pro forma constant currency... ► Artikel lesen | ||
| Mi | The Brunner Investment Trust - An 'all-weather' fund for global investors | 112 | The Brunner Investment Trust (BUT) has welcomed another experienced manager into its team. Julian Bishop joined Allianz Global Investors (AllianzGI) on 1 November 2022, following the departure of Matthew... ► Artikel lesen | ||
| Mi | Britvic - Strong growth despite headwinds | 207 | Britvic reported strong double-digit revenue growth across all business units in FY22, reflecting brand resilience despite significant headwinds. Trading benefited from a full year with no COVID-19-related... ► Artikel lesen | ||
| Mi | Induction Healthcare Group - Secured outlook | 130 | On a pro forma basis, Induction Healthcare's FY22 results were in line with our forecasts and market consensus, with revenues up 8x y-o-y to £12.1m and a move to adjusted EBITDA break-even. Contract... ► Artikel lesen | ||
| Mi | Murray Income Trust - Attractive income at a discount | 133 | Murray Income Trust (MUT) invests mainly in UK equities and aims to provide a high and growing income, combined with capital growth. The trust is meeting these three objectives. The FY23 dividend is... ► Artikel lesen | ||
| Di | AAC Clyde Space - Gathering momentum into 2023 | 195 | AAC Clyde Space's Q322 report showed improved momentum but also the deferral of project milestones into FY23 from FY22 as some satellite launches are delayed. We expect the positive momentum to continue... ► Artikel lesen | ||
| Di | The Bankers Investment Trust - Maintaining a defensive tilt | 134 | In our update on The Bankers Investment Trust (BNKR) in August, we updated readers on fund manager Alex Crooke's macroeconomic views and positioning. As one would expect, there have not been wholesale... ► Artikel lesen | ||
| Di | Medlab Clinical - UK compassionate use for alternative to opioids | 153 | Medlab Clinical has announced that it has received approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for its lead product NanaBis (NanaDol in the UK) to be used under its... ► Artikel lesen | ||
| 28.11. | Respiri - Commercialization efforts gathering steam | 192 | The Respiri/Access Telehealth collaboration continues to make steady gains in the US with the partners announcing their fourth commercial deal to date, with Arkansas Heart Hospital (AHH), a healthcare... ► Artikel lesen | ||
| 28.11. | Princess Private Equity - Portfolio resilient, holding-level liquidity strained | 199 | Princess Private Equity Holding's (PEY's) portfolio has fared quite well in 2022, with the +3.7% NAV total return (TR) in Q322 bringing the 9M22 TR decline to a moderate 4.0%. This was likely assisted... ► Artikel lesen | ||
| 28.11. | Provaris Energy - Q3 activity update highlights key milestones | 228 | The Q322 update from Provaris neatly summaries not only the significant progress made in the period, but highlights further progress already made in the early weeks of Q4 and other key announcements... ► Artikel lesen | ||
| 28.11. | Custodian REIT - Robust EPRA earnings but decreased NAV | 180 | Strong leasing activity is supporting EPRA earnings and Custodian REIT (CREI) is on track to meet its FY23 DPS target of not less than 5.5p, fully covered. Despite the robustness of occupational demand... ► Artikel lesen | ||
| 28.11. | Quadrise Fuels International - Key role in transitioning to net-zero | 209 | While there is much discussion about the use of green fuels to achieve net zero carbon emissions, in practice there are many hurdles to overcome before these can be widely deployed. Quadrise's synthetic... ► Artikel lesen | ||
| 28.11. | OPAP - Resilience prompts FY22 EBITDA upgrade | 318 | OPAP's strategy of greater product innovation, and the resilience of retail revenue despite increased pressures on consumer spending, drove solid revenue growth in Q322. Ongoing cost control led to... ► Artikel lesen | ||
| 28.11. | Vection Technologies - Enterprise-grade metaverse | 155 | Vection Technologies (ASX:VR1) is an Australia-based company that operates in the field of extended reality (XR). Through its immersive solutions suite, IntegratedXR, Vection Technologies provides the... ► Artikel lesen | ||
| 25.11. | Georgia Capital - Benefiting from strong macro tailwinds in Georgia | 218 | Georgia Capital's (GCAP's) NAV per share in Georgian lari (GEL) total return (TR) terms was 8.2% in Q322. At the same time, further GEL strength against sterling (driven by the strong local economy)... ► Artikel lesen | ||
| 24.11. | Kinarus Therapeutics - USPTO allows method-of-use KIN001 patent | 225 | Kinarus received a notice of allowability from the US Patent and Trademark Office (USPTO) for its patent application No. 16/500,504 ('methods of preventing or treating ophthalmic diseases') covering... ► Artikel lesen | ||
| 24.11. | CentralNic Group - Deleveraged and delivering growth | 224 | CentralNic (CNIC) delivered high double-digit organic revenue growth in the nine months to 30 September (9M22), supplemented by five acquisitions year to date. Revenues in Online Marketing, now the... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
